Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1320-1330

  Ye, Ming ^a   Duus, Karen M ^b   Peng, Junmin ^a   Price, David H ^a   Grose, Charles ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CYCLIN DEPENDENT KINASE; GLUTATHIONE; GLYCOPROTEIN; HYBRID PROTEIN; PROTEIN TYROSINE KINASE; TRANSFERRIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; EMBRYO; ENZYME PHOSPHORYLATION; HELA CELL; HERPES VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; VARICELLA ZOSTER VIRUS;

EID: 0032901995     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1320-1330.1999     Document Type: Article

References (60)

1. Alconada, A., U. Bauer, and B. Hoflack. 1996. A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network. EMBO J. 15:6096-6110.
2. Assouline, J. G., J. M. Levin, E. O. Major, B. Forghani, S. E. Straus, and J. M. Ostrove. 1990. Varicella-zoster virus infection of human astrocytes, schwann cells, and neurons. Virology 179:834-844.
3. Banham, A., and G. L. Smith. 1992. Vaccinia virus gene B1R encodes a 34 Kdal serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology 191:803-812.
4. Baptist, M., F. Lamy, J. Gannon, T. Hunt, J. E. Dumont, and P. P. Roger. 1996. Expression and suhcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles. J. Cell. Physiol. 166: 256-273.
5. cdc2. J. Biol. Chem. 270:25872-25878.
6. Cohen, J. I., and H. Nguyen. 1997. Varicella-zoster virus glycoprotein I is essential for growth of virus in Vero cells. J. Virol. 71:6913-6920.
7. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
8. Davison, A. J., D. J. Waters, and C. M. Edson. 1985. Identification of the products of a varicella-zoster virus glycoprotein gene. J. Gen. Virol. 66:2237-2242.
9. De Azevedo, W. F., S. Leclerc, L. Meijer, L. Havlicek, M. Strand, and S. Kim. 1997. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human CDK2 complexed with roscovitine. Eur. J. Biochem. 243: 518-526.
10. Doolittle, R. F. 1986. A primer on how to analyze derived amino acid sequences. University Science Books, Sausalito, Calif.
11. Duus, K. M., and C. Grose. 1996. Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J. Virol. 70:8961-8971.
12. Fuerst, F. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polyraerase. Proc. Natl. Acad. Sci. USA 83: 8122-8126.
13. Grana, X., A. D. Luca, N. Sang, Y. Fu, P. P. Claudio, J. Rosenblatt, D. O. Morgan, and A. Giordano. 1994. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. USA 91:3834-3838.
14. Grana, X., and E. P. Reddy. 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219.
15. Grose, C. 1990. Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annu. Rev. Microbiol. 44:59-80.
16. Grose, C., and P. A. Bruneill. 1978. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32°C. Infect. Immun. 19: 199-203.
17. Grose, C., W. Jackson, and J. A. Traugh. 1989. Phosphorylation of varicella-zoster virus gpI by mammalian casein kinase H and casein kinase 1. J. Virol. 63:3912-3918.
18. Guan, K., C. W. Jenkins, Y. Li, M. A. Nichols, X. Wu, C. L. O'Keefe, A. G. Matera, and Y. Xiong. 1994. Growth suppression by p18, a p16INK4/MTS1 and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8:2939-2952.
19. cyclin A. J. Biol. Chem. 266:17430-17440.
20. Jenkins, C. W., and Y. Xiong. 1995. Immunoprecipitation and immunoblotting in cell cycle studies, p. 250-263. In M. Pagano (ed.), Cell cycle: materials and methods. Springer-Verlag, New York, N.Y.
21. Kimura, H., S. E. Straus, and R. K. Williams. 1997. Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I. Virology 233:382-391.
22. Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44: 283-292.
23. Lew, J., Z. Qi, Q. Huang, H. Paudel, I. Matsuura, M. Matsushita, X. Zhu, and J. H. Wang. 1995. Structure, function, and regulation of neuronal cdc2-like protein kinase. Neurobiol. Aging 16:263-270.
24. Lin, S., and S. S. Broyles. 1994. Vaccinia protein kinase 2: a second essential serine/threonine protein kinase encoded by vaccinia virus. Proc. Natl. Acad. Sci. USA 91:7653-7657.
25. cdc2. Biochim. Biophys. Acta 1269:69-78.
26. cdc2. J. Biol. Chem. 266:20380-20389.
27. cdc2 in vitro and at mitosis. J. Biol. Chem. 267:13943-13951.
28. Litwin, V., W. Jackson, and C. Grose. 1992. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J. Virol. 66:3643-3651.
29. Mallory, S., M. Sommer, and A. M. Arvin. 1997. Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J. Virol. 71:8279-8288.
30. Marshall, N. F., J. Peng, Z. Xie, and D. H. Price. 1996. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271:27176-27183.
31. Marshall, N. F., and D. H. Price. 1995. Purification of p-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:12335-12338.
32. McGeoch, D. J., and S. Cook. 1994. Molecular phylogeny of the alphaher-pesvirinae subfamily and a proposed evolutionary timescale. J. Mol. Biol. 238:9-22.
33. Meijer, L., A. Borgne, O. Mulner, J. P. J. Chong, J. J. Blow, N. Inagaki, M. Inagaki, J. Delcros, and J. Moulinoux. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527-536.
34. Meyerson, M., G. H. Enders, C. Wu, L. Su, C. Gorka, C. Nelson, E. Harlow, and L. Tsai. 1992. A family of human cdc2-related protein kinase. EMBO J. 11:2909-2917.
35. cdc2: in vivo veritas? Cell 61:549-551.
36. Moss, B., O. Elroy-Stein, T. Mijukani, W. A. Alexander, and T. R. Fuerst. 1990. New mammalian expression vectors. Nature (London) 348:91-92.
37. Nagasawa, M., I. Melamed, A. Kupfer, E. W. Gelfand, and J. J. Lucas. 1997. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation. J. Immunol. 158:5146-5154.
38. Nasmyth, K. 1996. Viewpoint: putting the cell cycle in order. Science 74: 1643-1645.
39. Ng, T. I., and C. Grose. 1992. Serine protein kinase associated with varicella-zoster virus ORF 47. Virology 191:9-18.
40. Nigg, E. A. 1995. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471-480.
41. Olson, J. K., G. A. Bishop, and C. Grose. 1997. Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J. Virol. 71:110-119.
42. Olson, J. K., and C. Grose. 1998. Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J. Virol. 72:1542-1551.
43. Olson, J. K., and C. Grose. 1997. Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J. Virol. 71:4042-4054.
44. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
45. Peng, J., Y. Zhu, J. T. Milton, and D. H. Price. 1998. Identification of multiple cyclin subunits of human p-TEFb. Genes Dev. 12:755-762.
46. Phelps. D. E., and Y. Xiong. 1997. Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6. Methods Enzymol. 283:194-205.
47. Pines, J. 1995. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308:697-711.
48. Reynisdottir, I., and J. Massague. 1997. The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492-503.
49. Roizman, B., and A. E. Sears. 1996. Herpes simplex viruses and their replication, p. 2231-2295. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
50. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 16.33-16.37. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
51. Schang, L. M., J. Phillips, and P. A. Schaffer. 1998. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J. Virol. 72:5626-5637.
52. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
53. Smith, R F., and T. F. Smith. 1989. Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. J. Virol. 63:450-455.
54. Traugh, J. 1989. Approaches to examine the role of multiple serine protein kinases in the coordinate regulation of cell growth, p. 173-202. In J. J. Mond, J. C. Cambier, and A. Weiss (ed.). Advances in regulation of cell growth, vol. 1. Regulation of cell growth and activation. Raven Press, New York, N.Y.
55. Tugizov, S., E. Maidji, J. Xiao, Z. Zheng, and L. Pereira. 1998. Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells. J. Virol. 72: 7374-7386.
56. Yao, Z., and C. Grose. 1994. Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex). J. Virol. 68:4204-4211.
57. Yao, Z., W. Jackson, B. Forghani, and C. Grose. 1993. Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system. J. Virol. 67:305-314.
58. Yao, Z., W. Jackson, and C. Grose. 1993. Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpl. J. Virol. 67:4464-4473.
59. Yao, Z., D. H. Jones, and C. Grose. 1992. Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction. PCR Methods Appl. 1:205-207.
60. Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor p-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:2622-2632.